Stem Cell Centre

干细胞中心

• 批准号: STM002003
• 负责人: Dr David Collins
• 金额: $ 3334万
• 依托单位: NATIONAL STEM CELL FOUNDATION OF AUSTRALIA
• 依托单位国家: 澳大利亚
• 项目类别: ARC Centres of Excellence
• 财政年份: 2003
• 资助国家: 澳大利亚
• 起止时间: 2003-01-01 至 2011-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/STM002003
• 关键词: Stem; Cell; Centre

Therapeutic products based on stem cell research provide great hope for many currently challenging areas of medical science, with the potential of improving the quality of life for millions of people. The range of indications that could potentially benefit from treatments developed from stem cell technologies includes: congestive cardiac failure or heart disease, insulin dependent diabetes, neurodegenerative disorders, osteoporosis and chronic obstructive pulmonary disease or lung disease. The ASCC aims to produce stem cell related research tools and regenerative medicines by combining expertise in adult and embryonic stem cells, tissue repair and immunology.

基于干细胞研究的治疗产品为目前许多具有挑战性的医学领域带来了巨大的希望，有可能改善数百万人的生活质量。可能从干细胞技术开发的治疗中受益的适应症范围包括：充血性心力衰竭或心脏病、胰岛素依赖型糖尿病、神经退行性疾病、骨质疏松症和慢性阻塞性肺病或肺病。ASCC旨在通过结合成人和胚胎干细胞，组织修复和免疫学的专业知识，生产干细胞相关的研究工具和再生药物。